ANI PHARMACEUTICALS INC 8-K

What Happened

• ANI Pharmaceuticals, Inc. (ANIP) announced its financial results for the fourth quarter and fiscal year ended December 31, 2025 via a press release dated February 27, 2026. The company filed an 8-K (Item 2.02) furnishing that press release as Exhibit 99.1 and included an Inline XBRL cover page (Exhibit 104).

Key Details

• Filing date: February 27, 2026 (8-K reporting Item 2.02 — Results of Operations and Financial Condition).
• Period covered: fourth quarter and fiscal year ended December 31, 2025.
• Press release furnished as Exhibit 99.1; Inline XBRL cover page provided as Exhibit 104.
• The 8-K furnishes the company's earnings/quarterly results information but does not include additional disclosures beyond the press release attachment.

Why It Matters

• This filing is the company’s official release of its recent earnings and revenue performance for Q4 and FY2025—key inputs for evaluating ANIP’s financial health.
• Investors should review the attached press release (Exhibit 99.1) and the Inline XBRL data for specific figures on revenue, earnings, and any management commentary or guidance that could affect the stock.
• Because the 8-K furnishes the press release, the release is available now for immediate review by shareholders and analysts seeking the latest quarterly and full-year results.